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Background: We aimed to evaluate the ICU management and long-term outcomes of kyphoscoliosis patients with
respiratory failure.
Methods: A retrospective observational cohort study was performed in a respiratory ICU and outpatient clinic from
2002–2011. We enrolled all kyphoscoliosis patients admitted to the ICU and followed-up at regular intervals after
discharge. Reasons for acute respiratory failure (ARF), ICU data, mortality, length of ICU stay and outpatient clinic
data, non-invasive ventilation (NIV) device settings, and compliance were recorded. NIV failure in the ICU and the
long term effect of NIV on pulmonary performance were analyzed.
Results: Sixty-two consecutive ICU kyphoscoliosis patients with ARF were enrolled in the study. NIV was initially
applied to 55 patients, 11 (20%) patients were intubated, and the majority had sepsis and septic shock (p < 0.001).
Mortality in the ICU was 14.5% (n = 9), reduced pH, IMV, and sepsis/septic shock were significantly higher in the
non-survivors (p values 0.02, 0.02, 0.028, 0.012 respectively). Among 46 patients attending the outpatient clinic, 17
were lost to follow up and six were died. The six minute walk distance was significantly increased in the final follow
up (306 m versus 419 m, p < 0.001).
Conclusions: We strongly discourage the use of NIV in the case of septic shock in ICU kyphoscoliosis patients with
ARF. Pulmonary performance improved with NIV during long term follow up.
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Kyphoscoliosis (KS) is characterized by diminished chest
wall compliance and impaired respiratory mechanics,
leading to progressive hypoventilation, hypercapnia and
chronic respiratory failure (CRF) [1]. Acute exacerbations,
particularly respiratory tract infections, rapidly worsen
these patients’ respiratory conditions and precipitate acute
respiratory failure (ARF), which usually requires intensive
care unit (ICU) hospitalization and either non-invasive or
invasive mechanical ventilation [2].
Non-invasive, positive pressure ventilation (NIV) has
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reproduction in any medium, provided the orwall diseases [3]. Following the use of NIV in kyphosco-
liosis patients with CRF, improvements in hypoventilation
symptoms and a reduction in hospital readmissions have
been shown [4-6]. However, ICU management and the
long-term, post-ARF/ICU outcomes are rarely reported in
these patients.
In the present study, we aimed to evaluate ICU man-
agement and long-term outcomes of patients with CRF
due to kyphoscoliosis.Methods
This study was conducted in a level III medical intensive
care unit at a tertiary education hospital. The study was
designed as a retrospective observational cohort study
between August 2002 and May 2011. Patients were fol-
lowed up for at least 12 months after discharge fromal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mittee of the government teaching hospital.
Patients
Kyphoscoliosis patients who were admitted to the med-
ical ICU with acute or acute-on-chronic hypercapnic re-
spiratory failure were enrolled in the study. ARF was
defined by the presence of acute breathing discomfort
and arterial blood gases values (ABG): partial arterial
oxygen pressure (PaO2) < 60 mmHg on room air, or
PaO2 over the fraction of inspired oxygen (PaO2/ FiO2)
<300, partial arterial carbon dioxide pressure (PaCO2)
≥ 45 mmHg and pH≤ 7.35 [7]. The reasons for ARF were
recorded as cor pulmonale [8], sepsis/septic shock [9] due
to pneumonia, lower respiratory tract infection, urinary
tract and blood stream infection.
Sepsis was defined as proven or strongly suspected in-
fection, and two of four criteria for systemic inflamma-
tory response syndrome: 1. A respiratory rate more than
20/min or partial carbon dioxide pressure less than
32 mmHg; 2. A heart rate of more than 90 beats/min; 3.
A temperature more than 38.3°C or less than 36.0°C; 4.
A white blood cell count of more than 12,000 cells/μl or
less than 4,000 cells/μl, or more than 10% immature
cells [9]. Septic shock was defined as sepsis-induced
hypotension (systolic blood pressure of less than
90 mmHg or a reduction of more than 40 mmHg from
baseline in absence of other causes of hypotension), and
patients requiring vasopressor to maintain a mean arter-
ial pressure of more than 70 mmHg despite adequate
fluid resuscitation [9].
Pneumonia was defined as the acute onset of symp-
toms suggestive of a lower respiratory tract infection
and radiographical evidence of a new infiltrate [10]. The
presence of a nosocomial infection on admission to ICU
was recorded, and all patients were treated according to
guidelines [11].
Assessment of mechanical ventilations
Non-invasive mechanical ventilation
NIV was delivered in pressure assist-control mode with
ICU mechanical ventilators via a double tube circuit with
a full-face mask. Pressure support (PS) was initially set at
10 cmH2O and gradually increased to a maximum of 30
cmH2O until the exhaled tidal volume was 8-10 ml/kg
and guided by patient tolerance. Positive end-expiratory
pressure (PEEP) was set at 5 cmH2O and raised if needed
to treat hypoxemia, or lowered to enhance patient com-
fort. The fraction of inspired oxygen (FiO2) was adjusted
to keep oxygen saturation (SaO2) at 90%. NIV was ap-
plied intermittently for periods of 1 to 4 h and initial
ABG samples were obtained at the end of first hour. The
duration of each session was determined by improve-
ment in ABG levels, the level of consciousness, andpatient compliance. The level of consciousness was
assessed by the Glasgow coma scale (GCS) [12].
Intubation and NIV failure criteria
NIV was considered to have failed if at least one of the
following criteria for endotracheal intubation (ET) oc-
curred: 1. Cardiac arrest or severe hemodynamic in-
stability (mean arterial pressure < 65 mmHg or the need
for vasoactive agents); 2. Respiratory arrest; 3. Mask in-
tolerance with agitation requiring sedation; 4. Severe dif-
ficulty clearing secretions; 5. Failure of gas exchange
within the first 1 to 4 h of NIV therapy; 6. Lack of im-
provement in consciousness [3,13].
Invasive mechanical ventilation
Invasive mechanical ventilation (IMV) was delivered in
pressure assist-control ventilation (PCV) mode and PS
was initially set at 10 cmH2O and then gradually
increased to a maximum of 30 cmH2O until the exhaled
tidal volume was 8-10 ml/kg, as with the NIV settings.
An intermittent sedation protocol was applied with mid-
azolam according to Richmond agitation-sedation scale
[14]. After cessation of sedation, patients were evaluated
for weaning. When patients were conscious and
hemodynamically stabile, a T-tube trial was performed,
and after 30 minutes patients were extubated according
to our weaning protocol. If there was still a demand for
mechanical ventilation after weaning due to hypercapnia
we preferred to continue with NIV. We prescribed
domiciliary NIV devices according to home mechanical
ventilation guidelines after a good response was achieved
by NIV during the ICU stay [15]. All patients received
education from a specialized NIV nurse for using these
NIV devices prior to discharge.
Follow up
Patients were evaluated for the efficacy of NIV and treat-
ment adherence in an outpatient clinic one month after
ICU discharge, and then at 3–6 months intervals. Treat-
ment efficacy was assessed by clinical status and ABG
values. IPAP (inspiratory positive airway pressure) and
EPAP (expiratory positive airway pressure) values of NIV
devices were recorded. The physiological and functional
parameters were compared with IPAP-EPAP and IPAP-
EPAP/weight as defined by Budweisser et al. [16]. Ob-
jective NIV usage was also measured by a specialized
NIV nurse at every outpatient clinic visit by checking
the built-in time counter of the NIV device. The NIV
compliance was defined by the use of NIV more than
four hours a day or > 20 hour a week [15].
Data collections
We recorded patients’ age, gender, body mass index
(BMI, kg/m2), Glasgow coma scale (GCS) [8], acute
Table 1 Patient’s comorbidity and ICU data
Pre ICU localization, n (%)
ward 39 (62.9)
Emergency department 17 (27.4)
Other ICU 6 (9.7)
Comorbid diseases, N (%) 46 (75.4)
Diabetes mellitus 4 (6.6)
Hypertension 20 (32.3)
Congestive heart failure 14 (22.6)
Renal failure 1 (1.6)
Domiciliary oxygen therapy, N (%) 15 (24.6)
Domiciliary ventilator therapy, N (%) 4 (6.5)
APACHE II on ICU admission, median(IQR) 15 (12–19)
Arterial blood gases on admission, median(IQR)
pH 7.34 (7.29-7.40)
PaCO2, mmHg 69.5 (61.0-81.7)
PaO2, mmHg 70.9 (54.3-84.2)
HCO3, mmol/l 37.7 (33.1-41.1)
PaO2/FiO2 192 (145–264)
ICU, intensive care unit; APACHE, acute physiology and chronic health
evaluation; PaO2, partial arterial oxygen pressure; PaCO2, partial arterial
carbondioxide pressure; FiO2, fraction of inspired oxygen; HCO3, hydrogen
bicarbonate; IQR, interquartile ratio.
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scores [17], ABG values on admission to ICU, co-
morbid diseases, causes of ARF, presence of oxygen ther-
apy, NIV or IMV (tracheostomy) use for long-term
home therapy prior to ICU stay, ICU respiratory man-
agement (need for NIV, ventilation mode and duration,
need for and duration of tracheal intubation, tracheos-
tomy), status on ICU discharge (deceased or alive) and
respiratory status/management on ICU discharge (spon-
taneous breathing, NIV, tracheostomy).
Arm span (largest distance across the middle fingers
when the arms are stretched horizontally sideways)
was used as the height of KF patients for BMI and
spirometry measurements [18]. The six-minute walk
test (6-MWT) was performed on eligible patients in
the follow up period, and the 6-minute walk distance
(6-MWD) was recorded (in meters) [19].
We also recorded pulmonary function tests, ABG
values at the first and last outpatient clinic admission,
treatment compliance, and whether the patient was
deceased or surviving. The total number of hospital and
ICU readmissions with additional ARF episodes were
obtained from the hospital electronic database.
Statistical analysis
A descriptive analysis was used for patients’ demographics,
ICU data. Survivors versus non-survivors and NIV success
versus NIV failure were compared by the Mann Whitney
U test for non-parametric continuous variables, and the χ2
test was used for dichotomous variable. The relationship
of IPAP-EPAP/weight with 6-MWD and PaCO2 and spir-
ometry results were evaluated with the Spearman’s corre-
lations test. The Wilcoxon two related sample test was
used for comparison of the first and last ABG and spirom-
etry test results during the follow up period. Median and
interquartile ratio was used for continuous variables. Count
and percentage were used when applicable. A p value < 0.05
was accepted as statistically significant.
Results
Patients
During the study period, 62 kyphoscoliosis patients (29
female) with ARF were included. Thirty-nine patients
were admitted from the ward, 17 from the emergency
department, and six from another ICU (Table 1). The
reasons for kyphoscoliosis were idiopathic (n = 42,
67.7%), post-rachitic (n = 9, 14.5%), rheumatologic dis-
ease (n = 7, 11.4%), post-poliomyelitis (n = 2, 3.2%) and
post-traumatic (n = 2, 3.2%). The median (interquartile
range) age was 52 (45–65) years, and median BMI was
23 (21–27) kg/m2. All patients were hypercapnic and 55
(88.7%) patients were both hypercapnic and hypoxemic.
The reasons for ICU admission were: two patients
(3.3%) had a home NIV device problem, 26 (41.9%) hadcor pulmonale, 26 (41.9%) had severe sepsis, and eight
(12.9%) had septic shock. Pneumonia was diagnosed in
17 patients, seven of which had septic shock. Other rea-
sons for sepsis were urinary tract infection (n = 3), lower
respiratory tract infection (n = 13), and blood stream in-
fection (n = 1). Patients’ comorbidity and domiciliary
devices (NIV or oxygen), and ABGs values on admission
to the ICU are shown in Table 1.
Assessment of mechanical ventilation
In the study period, seven patients (11.4%) initially
received IMV (two via tracheostomy) and 55 (88.6%)
patients received NIV. Eleven patients (17.7%) were intu-
bated after initial NIV application. Two patients died dur-
ing NIV therapy due to acute myocardial infarction. The
overall NIV success rate was 76.4% (42/55). Mechanical
ventilation and ICU outcomes are shown in Figure 1. Five
NIV failures and two patients who were initially intu-
bated died because of sepsis with a resistant pathogen.
All intubated and tracheostomized (n = 2) patients
were ventilated in pressure assist-control mode with the
median (IQR) PS 17 (10–19) cmH2O to get tidal volume
8–10 ml/kg and PEEP to 6 (5–6) cmH2O. During NIV
applications, the median PS was 15 (10–19) cmH2O and
PEEP was 6 (5–6) cm H2O; the median NIV hours per
day were 11.0 (9.2-12.9). None of the patients had
pneumothorax. The median length of stay in the ICU
was 8 (5–14) days. The overall ICU mortality was 14.5%
2 (%4.5) 5(%45.4) 2(%28.6)








Figure 1 Mechanical ventilation outcomes of kyphoscoliosis
patients in intensive care unit.
Table 3 Arterial blood gases values on admission to the
ICU and after the first hour of NIV in patients with NIV
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tion support). Five patients were tracheostomized due to
weaning failure. Surviving and non-surviving patients
were further compared according to gender, age, initial
ABGs, mechanical ventilation (IMV or NIV), and the
presence of sepsis and septic shock on admission to the
ICU (Table 2). The non-surviving kyphoscoliosis patients
had significantly lower pH values, a higher rate of IMV,
and a higher rate of sepsis and septic shock (Table 2)
(p values were 0.02, 0.02, 0.028, 0.012 respectively).
Both groups had a statistically similar length of stay
in the ICU (p = 0.40) (Table 2).Table 2 A comparison patient data of survivors versus






Gender, male/female 29/24 4/5 0.72
Age, years 51 (45–64) 62 (45–70) 0.49
APACHE II, median(IQR) 15 (12–19) 16 (14–19) 0.26
pH on admission,
median(IQR)
7.37 (7.30-7.40) 7.29 (7.28-7.31) 0.02
PaCO2 on admission,
median(IQR)
69.0 (60.1-80.8) 80.0 (73.0-83.0) 0.10
PaO2/FiO2, median(IQR) 195 (147–275) 161 (145–189) 0.08
IMV, n (%) 11 (20.8) 7 (77.8) 0.02
NIV, n (%) 48 (90.6) 7 (77.8) 0.26
Sepsis on admission, n (%) 19 (35.8) 7 (77.8) 0.028
Septic shock on admission,
n (%)
4 (7.5) 4 (44.4) 0.012
Length of stay in ICU, day 8 (5–14) 13 (8–18) 0.40
ICU, intensive care unit; IQR, interquartile ratio; APACHE, acute physiology and
chronic health evaluation; PaCO2, partial arterial carbondioxide pressure; PaO2,
partial arterial oxygen pressure; FiO2, fraction of inspired oxygen; IMV, invasive
mechanical ventilation; NIV, non-invasive mechanical ventilation.In the 55 patients who received NIV ABGs values were
obtained on admission to the ICU and after the first
hour of NIV, to assess NIV response (summarized in
Table 3). NIV failure patients had significantly lower pH
values at admission and after the first hour of NIV
(p < 0.005, p < 0.026 respectively, Table 3).
There were 13 patients where NIV failed; 11 were
intubated for IMV and two died due to myocardial in-
farction during NIV. A significantly higher rate of sep-
sis/septic shock was found in the NIV failure patients
(n = 11/13) than in the NIV success patients (n = 16/42)
(p < 0.004, χ square, fisher exact test, Figure 2).
Follow up period
Fifty-three patients were discharged from ICU (18 to
home, 35 to the the ward). Two patients died in the
ward and overall hospital mortality was 17.7% (n = 11).
The long-term follow up outcomes are summarized in
Figure 3.
After the initial one-month follow up at the outpatient
clinic, 29 patients were followed-up for longer than
12 months. The median (IQR) follow up was 48 months
(24–65) and NIV compliance rate was 79.3%. The re-
hospitalization of eight of these 29 patients was recorded
during the follow up period and they were re-admitted
19 times for pneumonia (n = 8), pulmonary embolism
(n = 3), acute cor pulmonale (n = 5), pneumothorax








14 (12–16) 20 (17–23) 0.001
GCS, median(IQR) 15 (14–15) 14 (10–15) 0.002
Respiratory
rate, median(IQR) [bpm]
25 (22–31) 26 (19–37) 0.58
ABGs on admission to the ICU, median(IQR)
pH 7.37 (7.30-4.40) 7.28 (7.26-7.32) 0.005
paCO2, mmHg 69.0 (61.2-78.6) 81.6 (72.5-93.2) 0.015
PaO2/FiO2 201 (149–274) 161 (137–191) 0.12
HCO3, mmol 37.7 (33.2-41.2) 38.9 (33.1 -41.1) 0.74
First control ABGs after NIV, median(IQR)
pH 7.38 (7.34-7.42) 7.29 (2.25-7.40) 0.026
paCO2, mmHg 62.9 (55.6-77.7) 77.0 (57.8-90.6) 0.07
PaO2/FiO2 234 (202–293) 193 (137–219) 0.015
HCO3, mmol 35.4 (33.0-40.0) 36.4 (32.5-39.8) 0.74
ABG, arterial blood gas; ICU, intensive care unit; IQR, interquartile ratio;
APACHE, acute physiology and chronic health evaluation; GCS, Glascow Coma
Scale; bpm, breaths per minute; PaCO2, partial arterial carbondioxide pressure;




















Figure 2 Sepsis in patients with non-invasive ventilation success and failure.
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etry and 6-MWD) are summarized in Table 4.
Median IPAP and EPAP of NIV device were 20 (18–25)
cmH2O, and 5 (5–6) cm H2O respectively in initial follow
up. The median IPAP-EPAP difference was 15 (12–19)
cmH2O, and the median IPAP-EPAP/weight ratio was
0.26 (0.16-0.31). The relationship between IPAP-EPAP/
weight with 6-MWD, PaCO2 and spirometry results
were evaluated with Spearman’s correlations test.
IPAP-EPAP/weight ratio was significantly positively
correlated with 6-MWD (r=0.49, p= 0.029) but no correl-
ation was found between PaCO2 and spirometry test
results.
Discussion
In the present study we evaluated acute and chronic re-
spiratory failure management and outcomes in a sub-
stantial population of the rare disease kyphoscoliosis.ICU discharge, n= 53 p
Long term NIVLong term oxygen,n=10




lost n= 7lost n=10
Follow  up,
Figure 3 Follow-up outcomes of kyphoscoliosis patients.The success rate of applying non-invasive mechanical
ventilation in kyphoscoliosis patients with acute respira-
tory failure was found to be 76.4% in our ICU. The rate
of sepsis in patients with NIV failure was higher than in
patients with NIV success. The mortality rate was higher
in patients in ICU with NIV failure, using IMV, and with
septic shock. The prescription rates of long-term mech-
anical ventilation and NIV compliance were 70.6% and
79.3% respectively. The six-minute walk distance
increased significantly after long-term NIV.
There are currently no reports on the reasons why
kyphoscoliosis patients with acute respiratory failure re-
quire ICU admission and mechanical ventilation. How-
ever, pneumonia and cor pulmonale are seen in one
third of hospitalized chronic obstructive pulmonary dis-
ease (COPD) patients with NIV [20]. The primary rea-
sons for ARF in our kyphoscoliosis patients were cor
pulmonale and sepsis. Pneumonia was the primary causeatients





died at ward, n=2
died n= 5
n=46
Table 4 Long-term pulmonary function tests of
kyphoscoliosis patients
First control Last control
Median (IQR) Median (IQR) p*
pH 7.43 (7.41-7.44) 7.43 (7.40-7.46) 0.001
PaCO2 47.7 (44.0-53.9) 50.4 (46.3-54.0) 0.18
PaO2/FiO2 300 (275–332) 304 (269–328) 0.75
HCO3mmol 31.0 (28.6-35.3) 32.1 (30.1-34.8) 0.44
FEV1, ml 670 (550–860) 840 (520–940) 0.46
FEV1% 34 (18–40) 35 (21–44) 0.50
FVC, ml 830 (740–1100) 955 (640–1160) 0.35
FVC% 32 (21–38) 34 (22–41) 0.50
FEV1/FVC 82 (78–89) 88 (81–91) 0.87
6-MWD, m 306 (220–405) 419 (348–462) 0.001
Wilcoxon two related sample test. PaCO2, partial arterial carbondioxide
pressure; PaO2, partial arterial oxygen pressure; FiO2, fraction of inspired
oxygen; HCO3, Hydrogen bicarbonate, FEV1, forced expiratory volume in
1 second; FVC, forced vital capacity; 6-MWD, 6 minute walking distance.
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higher mortality rate than initially intubated patients.
This may be related to delayed intubation due to a min-
imal improvement of ABG values after the first hour of
NIV treatment. NIV success patients had a 4.5 percent
mortality rate (Figure 1).
NIV failure risk factors in COPD are well studied and
defined with guidelines [3,21-23]. Confalonieri and co-
workers presented a chart where NIV failure in patients
with COPD was in a red zone [23]. Patients in the red
zone had a respiratory rate ≥ 30, GCS ≤ 11, pH< 7.25, and
an APACHE II score ≥ 29 on admission to ICU. These
were accepted as the most important parameters for NIV
failure criteria [23]. Although the patients presented here
were not diagnosed with COPD, NIV failure kyphoscolio-
sis patients in the ICU had a significantly higher APACHE
II score and respiratory rate, but lower GCS and pH values
(20 versus 14 score; 26 versus 25 breath /min, 14 versus 15
score; 7.28 versus 7.37, respectively). These results were not
as severe as those observed in NIV failure due to COPD, as
described [3,21-23].Follow up
NIV compliance for long-term usage varies according to
the underlying diseases, such as COPD, obesity
hypoventilation, neuromuscular disease and kyphosco-
liosis. The NIV compliance rate of kyphoscoliosis
patients is currently reported to be between 79 and 90%
[24-26]. In the present study, 29 kyphoscoliosis patients
with NIV were tightly compliant to the outpatient clinic
controls. Patients without a NIV device (n = 10) did not
attend the outpatient clinic. The NIV compliance rate
(>4 hours a day) was 79.3%.Volume or pressure cycled NIV settings have previ-
ously been used for long-term home therapy and both
have showed similar results in various studies [3,27-29].
We used pressure cycled NIV devices. Budweiser and co-
workers showed that PS greater than 15 cmH2O
improved the decrease in PaCO2 for long-term follow up
in patients with restrictive thoracic diseases [16]. They
concluded that IPAP-EPAP/weight ratio correlated with
the PaCO2 decrease at the initial follow up after hospital
discharge with long-term NIV [16]. However we did not
find any correlation between ΔPaCO2 and IPAP-EPAP/
weight and the initial outpatient clinic data (pulmonary
function, 6-MWD and ABG values). IPAP-EPAP/weight
ratio was significantly correlated with 6-MWD but not
with the other parameters. A recent review which evalu-
ated 41 studies published over an 18 year period, looked
at the physiological effects of NIV on work-of-breathing
(WOB), pressure-support of 15 cmH2O and a PEEP of
5 cmH2O, and showed reduced WOB in patients primarily
with chronic pulmonary disease including kyphoscoliosis
[30]. In the present study IPAP was, in most cases, set
greater than 20 cmH2O, and EPAP was set as 5 cmH2O,
similar to previous studies [16,30].
The mortality rates of kyphoscoliosis patients with long-
term domiciliary NIV therapy have been reported as 9.5%
over two years, and 21% over five years [26,28]. In the
present study the mortality rate was 20.7% over 4 years.
There are some limitations in our study. Firstly, we
designed it retrospectively and in one center. Secondly,
the physiological respiratory muscle function tests (ie,
diaphragm functions) and the measurement of the de-
gree of spinal curvature were not done. The use of the
degree of curvature and the severity of respiratory failure
relation is controversial [31,32]. Thirdly, the ICU mortal-
ity risk analysis was not done due to small number of
non-surviving patients.Conclusion
Kyphoscoliosis patients with respiratory failure due to
pump failure have a mainly good response to NIV. How-
ever, in specific disease groups and the presence of sepsis/
septic shock NIV failure may result. For this reason we
strongly discourage the use of NIV in the case of septic
shock. Although this is a single center study and we can-
not generalize the results for all patients, this study may
help to make a decision on the clinical management of
kyphoscoliosis patients with ARF in the ICU. Pulmonary
function tests and 6-MWD of kyphoscoliosis patients can
improve with nearly 15 cmH2O pressure support with
pressure cycled NIV devices during long term follow up.
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